Back to Search
RICHARD STONE, MD
MD
Hematology & Oncology Physician
NPI: 1528036894IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
53417(MA)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
HARVARD MEDICAL SCHOOL
Class of 1981
Research & Publications (20)
A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804.
PMID 18670778·Cancer Chemother Pharmacol·2009
3-trial
Recent advances in low- and intermediate-1-risk myelodysplastic syndrome: developing a consensus for optimal therapy.
PMID 19385003·Clin Adv Hematol Oncol·2008
8-other
Are new agents really making a difference in MDS?
PMID 19041603·Best Pract Res Clin Haematol·2008
6-review
Timed sequential induction chemotherapy in AML: time for reflection.
PMID 18828158·Am J Hematol·2008
8-other
Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission.
PMID 18756547·Am J Hematol·2008
3-trial
Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412.
PMID 15345597·Blood·2005
3-trial
Pathology quiz case 2. First branchial cleft cyst.
PMID 15545595·Arch Otolaryngol Head Neck Surg·2004
5-case
Optimizing treatment of chronic myeloid leukemia: a rational approach.
PMID 15169981·Oncologist·2004
6-review
PKC 412 FLT3 inhibitor therapy in AML: results of a phase II trial.
PMID 15124689·Ann Hematol·2004
3-trial
Platelet-derived growth factor receptor inhibition to treat idiopathic hypereosinophilic syndrome.
PMID 15175999·Semin Oncol·2004
6-review
Treatment of acute myeloid leukemia: state-of-the-art and future directions.
PMID 12214287·Semin Hematol·2002
6-review
Postremission therapy in adults with acute myeloid leukemia.
PMID 11474493·Semin Hematol·2001
6-review
Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine.
PMID 11468148·Blood·2001
3-trial
Management of oral mucositis at European transplantation centres.
PMID 17540296·Eur J Oncol Nurs·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 44 BINNEY STREET
BOSTON, MA 02115 - Phone
- (617) 632-2214
Quick Facts
- NPI
- 1528036894
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 45
- Publications
- 20
Are you this provider?
Claim Your Profile